These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 21122914)

  • 1. Real-time monitoring of sustained drug release using the optical properties of porous silicon photonic crystal particles.
    Wu EC; Andrew JS; Cheng L; Freeman WR; Pearson L; Sailor MJ
    Biomaterials; 2011 Mar; 32(7):1957-66. PubMed ID: 21122914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrosilylated porous silicon particles function as an intravitreal drug delivery system for daunorubicin.
    Hartmann KI; Nieto A; Wu EC; Freeman WR; Kim JS; Chhablani J; Sailor MJ; Cheng L
    J Ocul Pharmacol Ther; 2013 Jun; 29(5):493-500. PubMed ID: 23448595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring of degradation of porous silicon photonic crystals using digital photography.
    Ariza-Avidad M; Nieto A; Salinas-Castillo A; Capitan-Vallvey LF; Miskelly GM; Sailor MJ
    Nanoscale Res Lett; 2014; 9(1):410. PubMed ID: 25242902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tunable sustained intravitreal drug delivery system for daunorubicin using oxidized porous silicon.
    Hou H; Nieto A; Ma F; Freeman WR; Sailor MJ; Cheng L
    J Control Release; 2014 Mar; 178():46-54. PubMed ID: 24424270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A sustained intravitreal drug delivery system with remote real time monitoring capability.
    Hou H; Nieto A; Belghith A; Nan K; Li Y; Freeman WR; Sailor MJ; Cheng L
    Acta Biomater; 2015 Sep; 24():309-21. PubMed ID: 26087110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidized porous silicon particles covalently grafted with daunorubicin as a sustained intraocular drug delivery system.
    Chhablani J; Nieto A; Hou H; Wu EC; Freeman WR; Sailor MJ; Cheng L
    Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):1268-79. PubMed ID: 23322571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suitability of porous silicon microparticles for the long-term delivery of redox-active therapeutics.
    Wu EC; Andrew JS; Buyanin A; Kinsella JM; Sailor MJ
    Chem Commun (Camb); 2011 May; 47(20):5699-701. PubMed ID: 21503283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Porous silicon in drug delivery devices and materials.
    Anglin EJ; Cheng L; Freeman WR; Sailor MJ
    Adv Drug Deliv Rev; 2008 Aug; 60(11):1266-1277. PubMed ID: 18508154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface engineering of porous silicon microparticles for intravitreal sustained delivery of rapamycin.
    Nieto A; Hou H; Moon SW; Sailor MJ; Freeman WR; Cheng L
    Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):1070-80. PubMed ID: 25613937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidation-triggered release of fluorescent molecules or drugs from mesoporous Si microparticles.
    Wu EC; Park JH; Park J; Segal E; Cunin F; Sailor MJ
    ACS Nano; 2008 Nov; 2(11):2401-9. PubMed ID: 19206408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanostructured porous silicon-polymer-based hybrids: from biosensing to drug delivery.
    Bonanno LM; Segal E
    Nanomedicine (Lond); 2011 Dec; 6(10):1755-70. PubMed ID: 22122584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The compatibility of hepatocytes with chemically modified porous silicon with reference to in vitro biosensors.
    Alvarez SD; Derfus AM; Schwartz MP; Bhatia SN; Sailor MJ
    Biomaterials; 2009 Jan; 30(1):26-34. PubMed ID: 18845334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of Surface Chemistry on the Release of an Antibacterial Drug from Nanostructured Porous Silicon.
    Wang M; Hartman PS; Loni A; Canham LT; Bodiford N; Coffer JL
    Langmuir; 2015 Jun; 31(22):6179-85. PubMed ID: 25970551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained antibacterial activity from triclosan-loaded nanostructured mesoporous silicon.
    Wang M; Coffer JL; Dorraj K; Hartman PS; Loni A; Canham LT
    Mol Pharm; 2010 Dec; 7(6):2232-9. PubMed ID: 20973523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photonic polymer replicas from distributed Bragg reflectors structured porous silicon.
    Kim J; Koh Y; Jang S; Ko YC; Woo HG; Sohn H
    J Nanosci Nanotechnol; 2007 Nov; 7(11):4165-8. PubMed ID: 18047143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal properties of porous silicon photonic crystals: a potential self-reporting intraocular drug-delivery vehicle.
    Cheng L; Anglin E; Cunin F; Kim D; Sailor MJ; Falkenstein I; Tammewar A; Freeman WR
    Br J Ophthalmol; 2008 May; 92(5):705-11. PubMed ID: 18441177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Green synthesis of Si-incorporated hydroxyapatite using sodium metasilicate as silicon precursor and in vitro antibiotic release studies.
    Abinaya Sindu P; Kolanthai E; Suganthi RV; Thanigai Arul K; Manikandan E; Catalani LH; Narayana Kalkura S
    J Photochem Photobiol B; 2017 Oct; 175():163-172. PubMed ID: 28888169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of nanoporous silicon layer to reduce the optical losses of crystalline silicon solar cells.
    Lee S; Lee E
    J Nanosci Nanotechnol; 2007 Nov; 7(11):3713-6. PubMed ID: 18047043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering porous silicon nanostructures as tunable carriers for mitoxantrone dihydrochloride.
    Tzur-Balter A; Gilert A; Massad-Ivanir N; Segal E
    Acta Biomater; 2013 Apr; 9(4):6208-17. PubMed ID: 23274152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of thermal oxidation on the luminescence properties of nanostructured silicon.
    Liu L; Sham TK
    Small; 2012 Aug; 8(15):2371-80. PubMed ID: 22549930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.